Sonoma Pharmaceuticals' Stunning 194% US Revenue Surge: What's Driving the Growth?

Petaluma, Tuesday, 16 June 2026.
Sonoma Pharmaceuticals reported a 48% revenue jump in Q4 2026, but the real headline is its 194% US revenue surge—tripling domestic sales in just one year. With losses shrinking and operational efficiency improving, is this the turnaround investors have been waiting for?